23andMe GCPM recaps and FDA meeting on Laboratory Developed Tests

You can find two nice recaps of last week's personalized medicine policy forum on Genomics Law Report and 23andMe's blog, The Spittoon. Also of interest today and tomorrow - the FDA is holding a public meeting to discuss issues surrounding the potential oversight of laboratory developed tests (a catagory which DTC genetic testing may fall into). You can find the agenda and links to the live (free) webcast here, or you could follow the #FDALDT hashtag on Twitter. The Washington Post published this nice piece over the weekend summarizing the issues.